These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


165 related items for PubMed ID: 7734977

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation.
    Suárez-Fueyo A, Ramos T, Galán A, Jimeno L, Wurtzen PA, Marin A, de Frutos C, Blanco C, Carrera AC, Barber D, Varona R.
    J Allergy Clin Immunol; 2014 Jan; 133(1):130-8.e1-2. PubMed ID: 24290282
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
    Möbs C, Ipsen H, Mayer L, Slotosch C, Petersen A, Würtzen PA, Hertl M, Pfützner W.
    J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mechanisms of immunotherapy in allergic rhinitis.
    Jayasekera NP, Toma TP, Williams A, Rajakulasingam K.
    Biomed Pharmacother; 2007 Jan; 61(1):29-33. PubMed ID: 17189678
    [Abstract] [Full Text] [Related]

  • 10. [Specific immunotherapy (hyposensitization) in allergic rhinoconjunctivitis. Meta-analysis of effectiveness and side effects].
    Klimek L, Malling HJ.
    HNO; 1999 Jul; 47(7):602-10. PubMed ID: 10463112
    [Abstract] [Full Text] [Related]

  • 11. Cytokine production by peripheral blood mononuclear cells following birch-pollen immunotherapy.
    Movérare R, Elfman L, Björnsson E, Stålenheim G.
    Immunol Lett; 2000 Jul 03; 73(1):51-6. PubMed ID: 10963811
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. IL-5 production by allergen-stimulated T cells following grass pollen immunotherapy for seasonal allergic rhinitis.
    Till S, Walker S, Dickason R, Huston D, O'Brien F, Lamb J, Kay AB, Corrigan C, Durham S.
    Clin Exp Immunol; 1997 Oct 03; 110(1):114-21. PubMed ID: 9353157
    [Abstract] [Full Text] [Related]

  • 16. Derp1-modified dendritic cells attenuate allergic inflammation by regulating the development of T helper type1(Th1)/Th2 cells and regulatory T cells in a murine model of allergic rhinitis.
    Yu S, Han B, Liu S, Wang H, Zhuang W, Huang Y, Zhang R.
    Mol Immunol; 2017 Oct 03; 90():172-181. PubMed ID: 28802126
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
    Nakai Y, Ohashi Y, Tanaka A, Kakinoki Y, Washio Y, Masamoto T, Yamada K, Nakai Y, Ohmoto Y.
    Acta Otolaryngol Suppl; 1998 Oct 03; 538():143-51. PubMed ID: 9879414
    [Abstract] [Full Text] [Related]

  • 19. Specific immunotherapy induces changes in spontaneous IgE synthesis.
    Sanz ML, de las Marinas MD, Ferrer M, Oehling A.
    Int Arch Allergy Immunol; 1995 Oct 03; 107(1-3):445-9. PubMed ID: 7613208
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.